
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The isoquinoline alkaloid berberine inhibits human cytomegalovirus replication by interfering with the viral Immediate Early-2 (IE2) protein transactivating activity.
Anna Luganini, Beatrice Mercorelli, Lorenzo Messa, et al.
Antiviral Research (2019) Vol. 164, pp. 52-60
Open Access | Times Cited: 51
Anna Luganini, Beatrice Mercorelli, Lorenzo Messa, et al.
Antiviral Research (2019) Vol. 164, pp. 52-60
Open Access | Times Cited: 51
Showing 1-25 of 51 citing articles:
Antiviral activity of berberine
Alicja Warowicka, Robert Nawrot, Anna Goździcka‐Józefiak
Archives of Virology (2020) Vol. 165, Iss. 9, pp. 1935-1945
Open Access | Times Cited: 143
Alicja Warowicka, Robert Nawrot, Anna Goździcka‐Józefiak
Archives of Virology (2020) Vol. 165, Iss. 9, pp. 1935-1945
Open Access | Times Cited: 143
Phytochemicals from Plant Foods as Potential Source of Antiviral Agents: An Overview
Tapan Behl, Gabriele Rocchetti, Swati Chadha, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 4, pp. 381-381
Open Access | Times Cited: 93
Tapan Behl, Gabriele Rocchetti, Swati Chadha, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 4, pp. 381-381
Open Access | Times Cited: 93
Mitochondria-targeting nanomedicine self-assembled from GSH-responsive paclitaxel-ss-berberine conjugate for synergetic cancer treatment with enhanced cytotoxicity
Yu Cheng, Yuanhui Ji
Journal of Controlled Release (2019) Vol. 318, pp. 38-49
Closed Access | Times Cited: 85
Yu Cheng, Yuanhui Ji
Journal of Controlled Release (2019) Vol. 318, pp. 38-49
Closed Access | Times Cited: 85
Potential Antiviral Action of Alkaloids
Frage Abookleesh, Bader Al-Anzi, Aman Ullah
Molecules (2022) Vol. 27, Iss. 3, pp. 903-903
Open Access | Times Cited: 68
Frage Abookleesh, Bader Al-Anzi, Aman Ullah
Molecules (2022) Vol. 27, Iss. 3, pp. 903-903
Open Access | Times Cited: 68
A small molecule compound berberine as an orally active therapeutic candidate against COVID‐19 and SARS: A computational and mechanistic study
Zhenzhen Wang, Kun Li, Anish Maskey, et al.
The FASEB Journal (2021) Vol. 35, Iss. 4
Open Access | Times Cited: 58
Zhenzhen Wang, Kun Li, Anish Maskey, et al.
The FASEB Journal (2021) Vol. 35, Iss. 4
Open Access | Times Cited: 58
Application of molecular dynamics simulation in self-assembled cancer nanomedicine
Xueli Xu, Ao Liu, Shuangqing Liu, et al.
Biomaterials Research (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 30
Xueli Xu, Ao Liu, Shuangqing Liu, et al.
Biomaterials Research (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 30
Biologically active isoquinoline alkaloids covering 2019–2022
Dengtuo Wang, Lulu Qin, Chen-Xin Jing, et al.
Bioorganic Chemistry (2024) Vol. 145, pp. 107252-107252
Open Access | Times Cited: 10
Dengtuo Wang, Lulu Qin, Chen-Xin Jing, et al.
Bioorganic Chemistry (2024) Vol. 145, pp. 107252-107252
Open Access | Times Cited: 10
Screening of Botanical Drugs Reveals the Potential Anti-human Adenovirus Activity of Berberine
Junyuan Cao, Hao Zhang, Jixiang Zhang, et al.
Antiviral Research (2025), pp. 106105-106105
Open Access | Times Cited: 1
Junyuan Cao, Hao Zhang, Jixiang Zhang, et al.
Antiviral Research (2025), pp. 106105-106105
Open Access | Times Cited: 1
The role of berberine in Covid-19: potential adjunct therapy
Ahmad O. Babalghith, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 6, pp. 2003-2016
Open Access | Times Cited: 32
Ahmad O. Babalghith, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 6, pp. 2003-2016
Open Access | Times Cited: 32
Unlocking the potential of Berberine: Advancing cancer therapy through chemosensitization and combination treatments
Anjana Sajeev, Bethsebie Sailo, Jyothsna Unnikrishnan, et al.
Cancer Letters (2024) Vol. 597, pp. 217019-217019
Closed Access | Times Cited: 6
Anjana Sajeev, Bethsebie Sailo, Jyothsna Unnikrishnan, et al.
Cancer Letters (2024) Vol. 597, pp. 217019-217019
Closed Access | Times Cited: 6
Bright and Early: Inhibiting Human Cytomegalovirus by Targeting Major Immediate-Early Gene Expression or Protein Function
Catherine S. Adamson, Michael Nevels
Viruses (2020) Vol. 12, Iss. 1, pp. 110-110
Open Access | Times Cited: 48
Catherine S. Adamson, Michael Nevels
Viruses (2020) Vol. 12, Iss. 1, pp. 110-110
Open Access | Times Cited: 48
Alkaloids: Therapeutic Potential against Human Coronaviruses
Burtram C. Fielding, Carlos da Silva Maia Bezerra Filho, Nasser S. M. Ismail, et al.
Molecules (2020) Vol. 25, Iss. 23, pp. 5496-5496
Open Access | Times Cited: 48
Burtram C. Fielding, Carlos da Silva Maia Bezerra Filho, Nasser S. M. Ismail, et al.
Molecules (2020) Vol. 25, Iss. 23, pp. 5496-5496
Open Access | Times Cited: 48
New trends in the practical use of isoquinoline alkaloids as potential drugs applicated in infectious and non-infectious diseases
Tomasz Tuzimski, Anna Petruczynik
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115704-115704
Open Access | Times Cited: 16
Tomasz Tuzimski, Anna Petruczynik
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115704-115704
Open Access | Times Cited: 16
Systematic Review of Chemical Compounds with Immunomodulatory Action Isolated from African Medicinal Plants
Wendwaoga Arsène Nikiema, Moussa Ouédraogo, Windbedma Prisca Ouédraogo, et al.
Molecules (2024) Vol. 29, Iss. 9, pp. 2010-2010
Open Access | Times Cited: 5
Wendwaoga Arsène Nikiema, Moussa Ouédraogo, Windbedma Prisca Ouédraogo, et al.
Molecules (2024) Vol. 29, Iss. 9, pp. 2010-2010
Open Access | Times Cited: 5
Berberine: A Promising Natural Isoquinoline Alkaloid for the Development of Hypolipidemic Drugs
Dong‐Dong Li, Pan Yu, Wei Xiao, et al.
Current Topics in Medicinal Chemistry (2020) Vol. 20, Iss. 28, pp. 2634-2647
Closed Access | Times Cited: 37
Dong‐Dong Li, Pan Yu, Wei Xiao, et al.
Current Topics in Medicinal Chemistry (2020) Vol. 20, Iss. 28, pp. 2634-2647
Closed Access | Times Cited: 37
Residual and pharmacokinetic behavior of berberine in Carassius auratus under intraperitoneal injection conditions by HPLC-Q-TOF/MS
Shuai Zhang, Le Yang, Hao Jin, et al.
Journal of Chromatography B (2025) Vol. 1254, pp. 124507-124507
Closed Access
Shuai Zhang, Le Yang, Hao Jin, et al.
Journal of Chromatography B (2025) Vol. 1254, pp. 124507-124507
Closed Access
Metal-based nanoplatforms for enhancing the biomedical applications of berberine: current progress and future directions
Isaac Baidoo, Paromita Sarbadhikary, Heidi Abrahamse, et al.
Nanomedicine (2025), pp. 1-18
Open Access
Isaac Baidoo, Paromita Sarbadhikary, Heidi Abrahamse, et al.
Nanomedicine (2025), pp. 1-18
Open Access
Design of self-assembled micelles based on natural dual-targeting strategies and evaluation of their anti-liver cancer effects as drug delivery systems
Binbin Wang, Bai Lv, Hao Li, et al.
npj Precision Oncology (2025) Vol. 9, Iss. 1
Open Access
Binbin Wang, Bai Lv, Hao Li, et al.
npj Precision Oncology (2025) Vol. 9, Iss. 1
Open Access
The Clinically Approved Antifungal Drug Posaconazole Inhibits Human Cytomegalovirus Replication
Beatrice Mercorelli, Anna Luganini, Marta Celegato, et al.
Antimicrobial Agents and Chemotherapy (2020) Vol. 64, Iss. 10
Open Access | Times Cited: 31
Beatrice Mercorelli, Anna Luganini, Marta Celegato, et al.
Antimicrobial Agents and Chemotherapy (2020) Vol. 64, Iss. 10
Open Access | Times Cited: 31
Inhibition of the largemouth bass virus replication by piperine demonstrates potential application in aquaculture
Mengmeng Wang, Bin Yang, Zong‐Yi Ren, et al.
Journal of Fish Diseases (2022) Vol. 46, Iss. 3, pp. 261-271
Closed Access | Times Cited: 18
Mengmeng Wang, Bin Yang, Zong‐Yi Ren, et al.
Journal of Fish Diseases (2022) Vol. 46, Iss. 3, pp. 261-271
Closed Access | Times Cited: 18
Targeting natural products against SARS-CoV-2
Ahmed Al‐Harrasi, Tapan Behl, Tanuj Upadhyay, et al.
Environmental Science and Pollution Research (2022) Vol. 29, Iss. 28, pp. 42404-42432
Open Access | Times Cited: 16
Ahmed Al‐Harrasi, Tapan Behl, Tanuj Upadhyay, et al.
Environmental Science and Pollution Research (2022) Vol. 29, Iss. 28, pp. 42404-42432
Open Access | Times Cited: 16
Molecular modeling of some commercially available antiviral drugs and their derivatives against SARS-CoV-2 infection
Mohammad Arman, Safaet Alam, Rifat Alam Maruf, et al.
Narra J (2024) Vol. 4, Iss. 1, pp. e319-e319
Open Access | Times Cited: 3
Mohammad Arman, Safaet Alam, Rifat Alam Maruf, et al.
Narra J (2024) Vol. 4, Iss. 1, pp. e319-e319
Open Access | Times Cited: 3
Berberine in Human Oncogenic Herpesvirus Infections and Their Linked Cancers
Miroslava Šudomová, Kateřina Berchová‐Bímová, Stefania Marzocco, et al.
Viruses (2021) Vol. 13, Iss. 6, pp. 1014-1014
Open Access | Times Cited: 21
Miroslava Šudomová, Kateřina Berchová‐Bímová, Stefania Marzocco, et al.
Viruses (2021) Vol. 13, Iss. 6, pp. 1014-1014
Open Access | Times Cited: 21
Recent Applications of Protoberberines as Privileged Starting Materials for the Development of Novel Broad-Spectrum Antiviral Agents: A Concise Review (2017–2023)
Mehdi Valipour, Zahra Zakeri Khatir, Elaheh Abdollahi, et al.
ACS Pharmacology & Translational Science (2023) Vol. 7, Iss. 1, pp. 48-71
Closed Access | Times Cited: 7
Mehdi Valipour, Zahra Zakeri Khatir, Elaheh Abdollahi, et al.
ACS Pharmacology & Translational Science (2023) Vol. 7, Iss. 1, pp. 48-71
Closed Access | Times Cited: 7
Suppression effect of plant-derived berberine on cyprinid herpesvirus 2 proliferation and its pharmacokinetics in Crucian carp (Carassius auratus gibelio)
Meizhen Su, Ruizhe Tang, Hao Wang, et al.
Antiviral Research (2020) Vol. 186, pp. 105000-105000
Closed Access | Times Cited: 19
Meizhen Su, Ruizhe Tang, Hao Wang, et al.
Antiviral Research (2020) Vol. 186, pp. 105000-105000
Closed Access | Times Cited: 19